Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Today’s low
3935.50Today’s High
4009.0052W low
3051.0052W High
4100.00Open Price
4002.40Prev. Close
3753.80Volume
878622.00Value
3483428712.30Market Cap Cr
105249.00
Price to Earnings
76.10
Price to Book Value
8.20
Dividend Yield
0.80
PE to Growth
-1.80
Op Revenue TTM Cr
7492.77
Net Profit TTM Cr
1382.97
Cash From Operating Activity Cr
2459.73
Return on Equity %
14.28
EMA & SMA
Bullish Moving Averages
16
Bearish Moving Averages
0
DELIVERY AND VOLUME
02 May, 2024
Week
Month
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
PIVOT
First Resistance
4003.93
Second Resistance
4043.22
Third Resistance
4077.43
First Support
3930.43
Second Support
3896.22
Third Support
3856.93
Relative Strength Index
66.27
Money Flow Index
53.93
MACD
98.02
MACD Signal
73.97
Average True Range
88.53
Average Directional Index
29.36
Rate of Change (21)
15.07
Rate of Change (125)
16.49
Commodity Channel Index
136.9
Williams %R
-29.5
BETA
1 Month
-0.19
3 Month
0.55
1 Year
0.55
3 Year
0.09
PRICE CHANGE ANALYSIS
1 Week
Low
High
3790.55
4100
1 Month
Low
High
3555.2
4100
3 Months
Low
High
3350
4100
6 Months
Low
High
3295.3
4100
1 Year
Low
High
3051
4100
Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Graph |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Qtr Revenue cr | 1902.00 | 1953.00 | 1810.00 | 1974.32 | 1806.17 | 1902.63 | 2293.91 | 2545.54 | 2483.39 | 1986.97 | 1985.71 | |
Operating Expenses Qtr | 1317.00 | 1394.00 | 1239.00 | 1419.47 | 1280.41 | 1214.12 | 1366.34 | 1399.06 | 1366.87 | 1149.27 | 1098.69 | |
Operating Profit Qtr | 491.00 | 474.00 | 491.00 | 488.70 | 409.42 | 609.26 | 837.58 | 1095.97 | 1099.90 | 818.59 | 851.47 | |
EBIDT Qtr Cr | 585.00 | 559.00 | 571.00 | 554.85 | 525.76 | 688.51 | 927.57 | 1146.48 | 1116.52 | 837.70 | 887.02 | |
Depreciation Qtr | 95.00 | 94.00 | 93.00 | 86.63 | 86.54 | 85.48 | 83.42 | 80.75 | 79.70 | 77.09 | 73.01 | |
Net Profit Qtr | 358.00 | 342.00 | 345.00 | 318.79 | 310.90 | 486.85 | 691.61 | 882.96 | 907.22 | 606.39 | 551.97 | |
Basic EPS Qtr | 13.50 | 12.89 | 12.99 | 12.01 | 11.71 | 18.34 | 26.05 | 33.26 | 34.17 | 22.84 | 20.79 |
Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
---|---|---|---|---|---|---|
Total Revenue Annual | 7974.31 | 8991.08 | 6861.14 | 5500.43 | 5036.24 | |
Operating Expenses Annual Cr | 5277.62 | 5003.36 | 3977.93 | 3495.13 | 3030.70 | |
Operating Profit Annual | 2347.68 | 3876.46 | 2820.68 | 1815.44 | 1848.96 | |
Operating Profit Margin Annual % | 29.44 | 43.11 | 41.11 | 33.01 | 36.71 | |
Total Expenses Annual Cr | 5620.21 | 5314.56 | 4233.27 | 3687.14 | 3203.01 | |
EBIDT Annual Cr | 2696.69 | 3987.72 | 2883.21 | 2005.30 | 2005.54 | |
EBIDT Annual margin % | 33.82 | 44.35 | 42.02 | 36.46 | 39.82 | |
Depreciation | 342.07 | 310.55 | 254.65 | 185.95 | 168.81 | |
PAT Before ExtraOrdinary Items Annual Cr | 1808.15 | 2948.54 | 1954.72 | 1372.71 | 1332.65 | |
Net Profit Annual | 1808.15 | 2948.54 | 1954.72 | 1372.71 | 1332.65 | |
Basic EPS Annual | 68.11 | 111.07 | 73.63 | 51.71 | 50.20 |
Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
---|---|---|---|---|---|---|
Total ShareHolders Funds Annual | 12705.42 | 11691.35 | 9271.57 | 7316.69 | 6973.31 | |
Minority Interest Liability Annual Cr | - | - | - | - | - | |
Total Non Current Liabilities Annual Cr | 567.83 | 448.11 | 363.31 | 294.48 | 234.35 | |
Total Current Liabilities Annual Cr | 1078.37 | 1168.40 | 1088.89 | 902.94 | 832.52 | |
Total Capital Plus Liabilities Annual Cr | 14351.62 | 13307.86 | 10723.77 | 8514.11 | 8040.18 | |
Fixed Assets Annual | 4930.64 | 4790.90 | 4409.63 | 3695.95 | 2579.35 | |
Total Non Current Assets Annual | 5116.17 | 5011.90 | 4598.46 | 3852.94 | 3392.69 | |
Total Current Assets Annual | 9235.45 | 8295.96 | 6125.31 | 4661.17 | 4647.49 | |
Total Assets Annual | 14351.62 | 13307.86 | 10723.77 | 8514.11 | 8040.18 | |
Contingent Liabilities plus Commitments Annual Cr | 736.98 | 1259.90 | 1107.13 | 1223.83 | 1031.35 |
Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
---|---|---|---|---|---|---|
Cash from Operating Activity Annual | 2447.95 | 1910.16 | 1947.05 | 1208.47 | 964.06 | |
Cash from Investing Activity Annual | -2706.75 | -2195.40 | 75.34 | -81.38 | -684.24 | |
Cash from Financing Annual Activity | -796.59 | -531.50 | -33.97 | -1091.25 | -245.94 | |
Net Cash Flow Annual | -1055.39 | -816.74 | 1988.42 | 35.84 | 33.88 |
Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
---|---|---|---|---|---|---|
Book Value Per Share Annual | 478.64 | 440.44 | 349.28 | 275.63 | 262.70 | |
ROE Annual % | 14.23 | 25.21 | 21.08 | 18.76 | 19.11 | |
ROCE Annual % | 17.73 | 30.29 | 27.28 | 23.90 | 25.48 | |
Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | |
EBDIT Annual Margin % | 35.36 | 44.90 | 42.40 | 37.76 | 41.09 |
Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Graph |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Qtr Revenue cr | 1950.00 | 1995.00 | 1859.00 | 2016.92 | 1821.93 | 1934.62 | 2342.91 | 2570.83 | 2509.86 | 2006.62 | 1996.61 | |
Operating Expenses Qtr | 1366.00 | 1430.00 | 1274.00 | 1463.18 | 1299.40 | 1233.50 | 1407.82 | 1414.01 | 1396.06 | 1169.44 | 1108.59 | |
Operating Profit Qtr | 489.00 | 479.00 | 504.00 | 487.59 | 408.28 | 621.04 | 846.70 | 1104.43 | 1097.18 | 818.07 | 852.05 | |
EBIDT Qtr Cr | 584.00 | 565.00 | 585.00 | 553.74 | 522.53 | 701.12 | 935.09 | 1156.82 | 1113.80 | 837.18 | 888.02 | |
Depreciation Qtr | 95.00 | 95.00 | 93.00 | 87.02 | 86.77 | 85.73 | 83.66 | 80.99 | 79.91 | 77.35 | 73.26 | |
Net Profit Qtr | 358.00 | 348.00 | 356.00 | 320.97 | 306.80 | 493.60 | 702.01 | 894.64 | 902.24 | 606.46 | 557.11 | |
Basic EPS Qtr | 13.50 | 13.11 | 13.41 | 12.09 | 11.56 | 18.60 | 26.44 | 33.70 | 33.99 | 22.84 | 20.99 |
Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
---|---|---|---|---|---|---|
Total Revenue Annual | 8112.17 | 9073.70 | 7031.96 | 5584.05 | 5101.89 | |
Operating Expenses Annual Cr | 5399.69 | 5077.89 | 4109.46 | 3572.25 | 3074.42 | |
Operating Profit Annual | 2367.82 | 3881.94 | 2859.94 | 1822.17 | 1871.84 | |
Operating Profit Margin Annual % | 29.19 | 42.78 | 40.67 | 32.63 | 36.69 | |
Total Expenses Annual Cr | 5743.54 | 5390.20 | 4365.92 | 3764.59 | 3246.82 | |
EBIDT Annual Cr | 2712.48 | 3995.81 | 2922.50 | 2011.80 | 2027.47 | |
EBIDT Annual margin % | 33.44 | 44.04 | 41.56 | 36.03 | 39.74 | |
Depreciation | 343.18 | 311.51 | 255.59 | 186.24 | 168.90 | |
PAT Before ExtraOrdinary Items Annual Cr | 1823.38 | 2960.45 | 1984.29 | 1376.54 | 1352.74 | |
Net Profit Annual | 1823.38 | 2960.45 | 1984.29 | 1376.54 | 1352.74 | |
Basic EPS Annual | 68.69 | 111.52 | 74.75 | 51.85 | 50.96 |
Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
---|---|---|---|---|---|---|
Total ShareHolders Funds Annual | 12767.09 | 11728.18 | 9294.61 | 7309.92 | 6957.15 | |
Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Non Current Liabilities Annual Cr | 570.60 | 450.98 | 367.00 | 298.95 | 234.35 | |
Total Current Liabilities Annual Cr | 1101.08 | 1195.55 | 1112.46 | 926.83 | 846.75 | |
Total Capital Plus Liabilities Annual Cr | 14438.77 | 13374.71 | 10774.07 | 8535.70 | 8038.25 | |
Fixed Assets Annual | 4934.48 | 4794.98 | 4414.49 | 3701.54 | 2579.68 | |
Total Non Current Assets Annual | 5127.03 | 5023.21 | 4599.36 | 3855.87 | 3388.20 | |
Total Current Assets Annual | 9311.74 | 8351.50 | 6174.71 | 4679.83 | 4650.05 | |
Total Assets Annual | 14438.77 | 13374.71 | 10774.07 | 8535.70 | 8038.25 | |
Contingent Liabilities plus Commitments Annual Cr | 736.98 | 1259.90 | 1107.13 | 1222.84 | 1031.35 |
Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
---|---|---|---|---|---|---|
Cash from Operating Activity Annual | 2459.73 | 1911.80 | 1946.93 | 1215.94 | 954.30 | |
Cash from Investing Activity Annual | -2707.62 | -2194.92 | 75.13 | -83.47 | -685.40 | |
Cash from Financing Annual Activity | -797.17 | -532.44 | -34.89 | -1091.42 | -245.94 | |
Net Cash Flow Annual | -1045.06 | -815.56 | 1987.17 | 41.05 | 22.96 |
Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
---|---|---|---|---|---|---|
Book Value Per Share Annual | 480.96 | 441.82 | 350.15 | 275.38 | 262.09 | |
ROE Annual % | 14.28 | 25.24 | 21.34 | 18.83 | 19.44 | |
ROCE Annual % | 17.76 | 30.25 | 27.60 | 23.99 | 25.84 | |
Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | |
EBDIT Annual Margin % | 34.92 | 44.59 | 41.93 | 37.29 | 40.98 |
Name | Holding Percent | Holding Id | Pledged % | Locked % |
---|---|---|---|---|
SBI MUTUAL FUND | 7.85 | 74527780 | - | - |
AXIS MUTUAL FUND TRUSTEE LIMITED | 1.69 | 74527781 | - | - |
GOVERNMENT PENSION FUND GLOBAL | 1.23 | 74527789 | - | - |
Name | Holding Percent | Holding Id | Pledged % | Locked % |
---|---|---|---|---|
NILIMA PRASAD DIVI | 20.34 | 74527770 | 0 | 0 |
SATCHANDRA KIRAN DIVI | 20.34 | 74527771 | 0 | 0 |
SWARNA LATHA DIVI | 5.27 | 74527772 | 0 | 0 |
MURALI KRISHNA PRASAD DIVI | 2.85 | 74527773 | 0 | 0 |
DIVI'S BIOTECH PRIVATE LIMITED | 3.01 | 74527777 | 0 | 0 |
Name | Holding Percent | Holding Id |
---|---|---|
SBI MUTUAL FUND | 7.85 | 74527780 |
AXIS MUTUAL FUND TRUSTEE LIMITED | 1.69 | 74527781 |
GOVERNMENT PENSION FUND GLOBAL | 1.23 | 74527789 |
LIFE INSURANCE CORPORATION OF INDIA | 6.09 | 74527783 |
Name | Holding Percent | Holding Id |
---|
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
---|---|---|---|---|
Aug 11, 2023 | 30 | FINAL | Aug 11, 2023 | Equity Share |
Aug 11, 2022 | 30 | FINAL | Aug 12, 2022 | Equity Share |
Aug 17, 2021 | 20 | FINAL | - | Equity Share |
Feb 25, 2020 | 16 | INTERIM | Feb 26, 2020 | Equity Share |
Aug 14, 2019 | 16 | FINAL | - | Equity Share |
Aug 31, 2018 | 10 | FINAL | - | Equity Share |
Sep 15, 2017 | 10 | FINAL | - | Equity Share |
Mar 17, 2016 | 10 | INTERIM | Mar 18, 2016 | Equity Share |
Aug 06, 2015 | 20 | FINAL | - | Equity Share |
Jul 31, 2014 | 20 | FINAL | - | Equity Share |
Jul 25, 2013 | 15 | FINAL | - | Equity Share |
Jul 26, 2012 | 13 | FINAL | - | Equity Share |
Jun 16, 2011 | 10 | FINAL | - | Equity Share |
Jul 02, 2010 | 6 | FINAL | - | Equity Share |
Jun 15, 2009 | 6 | FINAL | - | Equity Share |
Jun 26, 2008 | 4 | FINAL | - | Equity Share |
Mar 23, 2007 | 10 | INTERIM | Mar 26, 2007 | Equity Share |
Aug 23, 2006 | 10 | FINAL | - | Equity Share |
Aug 11, 2005 | 8 | FINAL | - | Equity Share |
Jul 29, 2004 | 8 | FINAL | - | Equity Share |
Aug 11, 2003 | 6 | FINAL | - | Equity Share |
Ex-Date | Split Ratio | Record Date |
---|---|---|
Aug 03, 2007 | 10:2 | - |
Ex-Date | Purpose | Notes |
---|---|---|
Feb 10, 2024 | Quarterly Results | - |
Nov 06, 2023 | Quarterly Results | - |
Aug 14, 2023 | Quarterly Results | - |
May 20, 2023 | Audited Results & Final Dividend | - |
Feb 03, 2023 | Quarterly Results | - |
Nov 07, 2022 | Quarterly Results | - |
Aug 12, 2022 | Quarterly Results | - |
May 23, 2022 | Audited Results & Dividend | - |
Feb 11, 2022 | Quarterly Results | (Revised) |
Nov 06, 2021 | Quarterly Results | - |
Aug 07, 2021 | Quarterly Results | - |
May 29, 2021 | Audited Results & Final Dividend | - |
Feb 06, 2021 | Quarterly Results | - |
Nov 07, 2020 | Quarterly Results | - |
Aug 08, 2020 | Quarterly Results | - |
Jun 06, 2020 | Audited Results | - |
Feb 12, 2020 | Interim Dividend | - |
Feb 05, 2020 | Quarterly Results | - |
Nov 05, 2019 | Quarterly Results | - |
Aug 10, 2019 | Quarterly Results | - |
May 25, 2019 | Audited Results & Final Dividend | - |
Feb 02, 2019 | Quarterly Results | - |
Oct 27, 2018 | Quarterly Results | - |
Aug 04, 2018 | Quarterly Results | - |
May 26, 2018 | Audited Results & Dividend | - |
Jan 27, 2018 | Quarterly Results | - |
Oct 31, 2017 | Quarterly Results | - |
Jul 22, 2017 | Quarterly Results | - |
Jun 28, 2017 | Others | 1. Appointed Dr. Ramesh B. V. Nimmagadda as an Additional (Independent) Director w.e.f. 27th June, 2017. 2. Appointed Ms. Nilima Motaparti, as an Additional (Whole-time) Director w.e.f. 27th June,2017 |
May 26, 2017 | Audited Results & Dividend | - |
Feb 04, 2017 | Quarterly Results | - |
Nov 12, 2016 | Quarterly Results | - |
Aug 12, 2016 | Quarterly Results | - |
May 28, 2016 | Audited Results & Final Dividend | Interalia, has recommended the interim dividend declared as final dividend for the year ended March 31, 2016. |
Mar 10, 2016 | Interim Dividend | - |
Feb 05, 2016 | Quarterly Results | Approved to shift the Registered Office of the Company. |
Oct 31, 2015 | Quarterly Results | - |
Aug 08, 2015 | Quarterly Results | - |
May 23, 2015 | Audited Results & Dividend | - |
Jan 31, 2015 | Quarterly Results | - |
Nov 01, 2014 | Quarterly Results | - |
Aug 11, 2014 | Quarterly Results | - |
May 24, 2014 | Audited Results & Dividend | - |
Feb 03, 2014 | Quarterly Results | - |
Nov 08, 2013 | Quarterly Results | - |
Aug 03, 2013 | Quarterly Results | - |
May 20, 2013 | Audited Results & Dividend | - |
Feb 02, 2013 | Quarterly Results | - |
Nov 03, 2012 | Quarterly Results | - |
Aug 04, 2012 | Quarterly Results | - |
May 12, 2012 | Audited Results & Dividend | - |
Jan 28, 2012 | Quarterly Results | - |
Nov 01, 2011 | Quarterly Results | - |
Aug 06, 2011 | Quarterly Results | - |
May 20, 2011 | Audited Results & Dividend | - |
Feb 04, 2011 | Quarterly Results | - |
Nov 09, 2010 | Quarterly Results | - |
Aug 12, 2010 | Quarterly Results | - |
May 22, 2010 | Audited Results & Dividend | - |
Jan 29, 2010 | Quarterly Results | - |
Oct 30, 2009 | Quarterly Results | - |
Jul 31, 2009 | Quarterly Results | - |
Jun 06, 2009 | Audited Results, Dividend & Bonus | To recommend a issue of bonus shares in the ratio of one share for every share held, subject to approval of members. |
Apr 14, 2009 | Others | To seek shareholders approval by postal ballot for re-appointment of Mr. Madhusudana Rao Divi as Director (Projects) of the Co. & re-appointment of Mr. Kiran S Divi as Director of the Co. |
Jan 24, 2009 | Quarterly Results | - |
Oct 29, 2008 | Quarterly Results | - |
Jul 26, 2008 | Quarterly Results | - |
Jun 07, 2008 | Audited Results & Dividend | (Revised) |
Jan 28, 2008 | Quarterly Results | - |
Oct 27, 2007 | Quarterly Results | - |
Jul 30, 2007 | Quarterly Results | - |
May 23, 2007 | Audited Results & Stock Split | - |
Mar 17, 2007 | Interim Dividend | - |
Jan 27, 2007 | Quarterly Results | - |
Oct 28, 2006 | Quarterly Results | - |
Jul 31, 2006 | Quarterly Results | - |
Jun 17, 2006 | Accounts & Dividend | - |
Jan 30, 2006 | Quarterly Results & ESOP | - |
Oct 28, 2005 | Quarterly Results | - |
Jul 29, 2005 | Quarterly Results | - |
May 21, 2005 | Accounts & Dividend | - |
Jan 28, 2005 | Quarterly Results & Others | To consider the increasing of the limits of shareholding of Foreign Institutional Investors in the company. |
Oct 21, 2004 | Quarterly Results | (Revised) |
Jul 28, 2004 | Quarterly Results | - |
May 17, 2004 | Dividend & Accounts | - |
Jan 27, 2004 | Quarterly Results | - |
Oct 24, 2003 | Quarterly Results | - |
Jul 30, 2003 | Quarterly Results | - |
May 22, 2003 | Dividend & Accounts | - |
Ex-Date | Bonus Ratio | Record Date |
---|---|---|
Sep 23, 2015 | 1:1 | 2015-09-26 |
Jul 30, 2009 | 1:1 | 2009-08-01 |
DIVI'S LABORATORIES LTD. - 532488 - Information About Proposed Capacity Addition
Information about proposed capacity addition as per enclosed disclosure.DIVI'S LABORATORIES LTD. - 532488 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyDIVI''S LABORATORIES LTD. 2CIN NO.L24110TG1990PLC011854 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY AA+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CARE RATINGS LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkNSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: M Satish Choudhury Designation: Company Secretary and Compliance Officer EmailId: cs@divislabs.com Name of the Chief Financial Officer: L Kishore Babu Designation: Chief Financial Officer EmailId: kishore@divislabs.com Date: 12/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.DIVI'S LABORATORIES LTD. - 532488 - Compliance Certificate For The Year Ended March 31, 2024
Submission of compliance certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015.DIVI'S LABORATORIES LTD. - 532488 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
As per attachment.DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Clippings - Intimation of notice given to shareholders in respect of transfer of equity shares to IEPF accountDIVI'S LABORATORIES LTD. - 532488 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Submission of Scrutinizer''s Report on e-voting on resolutions stated in Postal Ballot Notice dated February 10, 2024.DIVI'S LABORATORIES LTD. - 532488 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Submisssion of Voting results on the resolutions proposed vide Postal Ballot Notice dated February 10, 2024 and Scrutinizer''s Report thereon.DIVI'S LABORATORIES LTD. - 532488 - Closure of Trading Window
Intimation of closure of Trading Window from April 01, 2024 for declaration of audited financial results for the fourth quarter and year ending March 31, 2024.DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement relating to Postal Ballot NoticeThe latest market price of Divi's Laboratories Ltd. on NSE was Rs. 3964.65 as of today.
The opening share price of Divi's Laboratories Ltd. was Rs. 4002.40 as of today.
The 52-week high share price of Divi's Laboratories Ltd. was Rs. 4100.00.
The 52 week low share price of Divi's Laboratories Ltd. was Rs. 3051.00.
Divi's Laboratories Ltd. has a market cap of Rs. 105249.00 crore as of today. Please refer to the Fundamentals section for further details.
The PE ratio of Divi's Laboratories Ltd. is -1.80. Please refer to the Fundamentals section for further details.
The operating revenue for Divi's Laboratories Ltd. in the last FY was Rs. 7492.77 crore. Please refer to the Financials section for further details.
The Net Profit for Divi's Laboratories Ltd. in the last FY was Rs. 1382.97 crore. Please refer to the Financials section for further details.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
The latest dividend declared by Divi's Laboratories Ltd. was on 2023-08-11 for Rs. 30 per share. According to today’s share price, the dividend yield of Divi's Laboratories Ltd. stands at 0.80. Please refer to the Corporate Actions section for further details.
The latest bonus issue declared by Divi's Laboratories Ltd. was as of 2015-09-23. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.
The latest split issue declared by Divi's Laboratories Ltd. was as of 2007-08-03. The split ratio declared in this issue was 10:2. Please refer to the Corporate Actions section for further details.
Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.
Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.
Please refer to the News section for the latest news about Divi's Laboratories Ltd..